1. 23andMe. (2014). 23andMe Personal Genome Service® (PGS) Performance Characteristics Summary Sheet. https://www.23andme.com/en-gb/performance-spec/ . (access date: 3.9.16).
2. 23andYou. (2016). http://www.23andyou.com/home . Tools for Everyone. (access date: 9.21.16).
3. American College of Obstetricians and Gynecologists (2016). Direct-to-consumer marketing of genetic testing. ACOG Committee Opinion No. 409. Obstet Gynecol 2008, 111, 1493–1494.
4. Armel, S. R., McCuaig, J., Gojska, N., Demsky, R., Maganti, M., Murphy, J., & Rosen, B. (2015). All in the family: barriers and motivators to the use of cancer family history questionnaires and the impact on attendance rates. Journal of Genetic Counseling, 24(5), 822–832.
5. Association for Molecular Pathology (AMP) (2015). Position Statement: direct access genetic testing (direct to consumer Genetic Testing) - February 2015. https://www.amp.org/publications_resources/position_statements_letters/documents/AMPpositionstatementDTCtesting-FINAL_002.pdf . (access date: 3.9.16).